MIODx Licenses Key Immunotherapy Technologies from UCSF – PR Newswire (press release)
|
MIODx Licenses Key Immunotherapy Technologies from UCSF
PR Newswire (press release) SAN JOSE, Calif., Feb. 23, 2017 /PRNewswire/ — MIODx announced today that it has signed an exclusive license for two key immunotherapy technologies from … UCSF Licenses Cancer Technology to MioDx | GenomeWeb |
